Welcome to our dedicated page for Molina Hlthcare news (Ticker: MOH), a resource for investors and traders seeking the latest updates and insights on Molina Hlthcare stock.
Molina Healthcare, Inc. reports developments tied to its managed healthcare business under Medicaid, Medicare and state insurance marketplace programs. Recurring updates include quarterly and annual results, premium revenue, medical care ratio trends, earnings guidance and commentary on state-program rates, medical cost management and product performance.
Company news also covers operating initiatives across Molina's service areas, including access-to-care and home health workforce programs, as well as capital actions such as senior note financing and credit-related activity. Coverage reflects a business model driven by government-program contracts, health plan membership, acquisitions, benefit costs and administrative expense control.
Molina Healthcare (NYSE: MOH) priced $850 million of 6.500% senior notes due February 15, 2031 in a Rule 144A/Reg S private offering, expected to close on or about November 20, 2025. Interest accrues from the Settlement Date and is payable semi‑annually on February 15 and August 15, commencing August 15, 2026. The notes will not be guaranteed by subsidiaries at issuance. After fees and expenses, estimated net proceeds are approximately $838 million. The company intends to use the net proceeds for general corporate purposes, including repaying outstanding delayed draw term loans under its credit agreement. The notes are unregistered under the Securities Act and restricted from resale in the U.S.
Molina Healthcare (NYSE: MOH) announced an intended private offering of $750 million aggregate principal amount of senior notes due 2031. The offering will be made under exemptions to the Securities Act, with sales limited to qualified institutional buyers under Rule 144A and certain non-U.S. persons under Regulation S. The notes will not be guaranteed by any subsidiaries at issuance, and interest rate, offering price and other terms are to be determined.
The company intends to use net proceeds to repay outstanding delayed draw term loans under its existing credit agreement. The notes will not be registered under the Securities Act and are subject to customary closing conditions.
Molina Healthcare (NYSE: MOH) said the Florida Agency for Health Care Administration intends to award Molina Healthcare of Florida a contract to serve as the sole plan for Statewide Medicaid Managed Care (SMMC) and CHIP services for the Title XIX/XXI Children’s Medical Services program.
Molina expects to serve approximately 120,000 enrollees. In calendar year 2025, total premiums under the program are expected to be about $5 billion. The contract is expected to run through December 31, 2030, though the official contract start date has not yet been determined.
Summary not available.
Molina Healthcare (NYSE: MOH) has scheduled its third quarter 2025 earnings release and conference call. The company will release its Q3 2025 financial results after market close on Wednesday, October 22, 2025.
The earnings conference call and webcast will be held on Thursday, October 23, 2025, at 8:00 a.m. Eastern Time. Investors can access the call by dialing (877) 883-0383 with confirmation number 2660919. A telephonic replay will be available through October 30, 2025, and a 30-day online replay will be accessible on the company's investor relations website.
Molina Healthcare (NYSE:MOH) reported Q2 2025 financial results with mixed performance and revised guidance. The company posted GAAP earnings of $4.75 per share (down 8% YoY) and adjusted EPS of $5.48 (down 6% YoY). Premium revenue increased 15% to $10.9 billion, driven by new contracts, acquisitions, and growth in current markets.
The company experienced challenges with medical cost trends, reporting a Medical Care Ratio (MCR) of 90.4%, up from 88.6% in Q2 2024. Membership grew to 5.7 million, an increase of 167,000 members year-over-year. Molina revised its full-year 2025 guidance, now expecting adjusted earnings of no less than $19.00 per share, while maintaining premium revenue guidance of approximately $42 billion.
Molina Healthcare (NYSE:MOH) has announced preliminary Q2 2025 financial results and revised its full-year guidance. The company expects Q2 2025 adjusted earnings of approximately $5.50 per share, below previous expectations, due to medical cost pressures across all business lines.
Due to anticipated continued cost pressures, MOH has updated its full-year 2025 adjusted earnings guidance to $21.50-$22.50 per share, with a consolidated pre-tax margin just under 4%. CEO Joseph Zubretsky characterized the earnings pressure as temporary, resulting from a dislocation between premium rates and accelerated medical cost trends.
Molina Healthcare (NYSE: MOH) reported strong Q1 2025 financial results with GAAP earnings of $5.45 per diluted share and adjusted earnings of $6.08 per diluted share. Premium revenue increased 12% year-over-year to $10.6 billion, driven by new contract wins, acquisitions, and growth in current markets.
The company served approximately 5.8 million members, up 25,000 from Q1 2024. The Medical Care Ratio (MCR) was 89.2%, with Medicaid at 90.3%, Medicare at 88.3%, and Marketplace at 81.7%. The G&A ratio improved to 6.9%.
Molina reaffirmed its full year 2025 guidance, expecting premium revenue of approximately $42 billion and adjusted earnings of at least $24.50 per diluted share. The company purchased approximately 1.7 million shares for $500 million in Q1 2025.
Molina Healthcare (NYSE: MOH) has secured a significant contract through its Illinois subsidiary as one of four managed care organizations selected by the Illinois Department of Healthcare and Family Services. The contract involves providing a Fully Integrated Dual Eligible Special Needs Plan (D-SNP), replacing the State's Medicare-Medicaid Alignment Initiative (MMAI) demonstration program that currently serves approximately 73,000 beneficiaries.
The new contract is scheduled to commence on January 1, 2026, with an initial term of four years and potential extensions up to a total of ten years.